251
Participants
Start Date
March 15, 2019
Primary Completion Date
May 12, 2020
Study Completion Date
December 22, 2020
Tezepelumab
Solution for injection
Placebo
Placebo solution for injection
Riga First Hospital, Riga
J Kisis, Riga
Clinic Latvian Dermatology Institute, Riga
Centre Hospitalier Universitaire Vaudois, Lausanne
Csalogany Orvosi Kozpont, Budapest
Obudai Egeszsegugyi Centrum Kft, Budapest
Holdsworth House Medical Practice, Sydney
The Royal Melbourne Hospital, Parkville
Skin Health Institute, Carlton
CRU Hungary Kft, Miskolc
Outpatient Clinic of Ventspils, Ventspils
Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz, Debrecen
Veracity Clinical Research, Woolloongabba
Fremantle Dermatology, Fremantle
Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar, Szeged
Pecsi Tudomanyegyetem Klinikai Kozpont, Pécs
Mount Sinai Hospital, New York
Charité Berlin, Berlin
DermResearch Center of New York Inc, Stony Brook
North Estonia Medical Centre, Tallinn
Hospital Universitario de La Princesa, Madrid
Hamilton Research, LLC, Alpharetta
Medizinische Hochschule Hannover, Hanover
Universitätsmedizin Göttingen - Georg-August-Universität, Göttingen
Tennessee Clinical Research Center, Nashville
Skin Sciences Pllc, Louisville
Scott Health Services LLC, Louisville
Hospital Universitario Virgen Macarena, Seville
DS Research, Clarksville
Clarkston Skin Research, Clarkston
Regional Skin and Venereal Dispensary, Dnipro
Clinical Research Centre, Tartu
Tartu University Hospital, Tartu
Chernivtsi Regional Skin and Venereal Dispensary, Chernivtsi
Dundee Dermatology, West Dundee
Southern Illinois University School of Medicine, Springfield
Epiphany Dermatology of Kansas, LLC, Overland Park
Military Hospital, Military Unit A3309 of the Military Medical Clinical Center, Zaporizhzhia
Modern Research Associates, Dallas
Ivano-Frankivsk Regional Skin and Venereal Dispensary, Ivano-Frankivsk
Asclepius, Uzhhorod
J Woodson Dermatology and Associates, Henderson
Clinical Science Institute, Santa Monica
First OC Dermatology, Fountain Valley
Premier Clinical Research, Spokane
Doctor Chih-Ho Hong Medical Incorporated, Surrey
DermEffects, London
Lynderm Research Inc, Markham
Cheema Research Incorporated, Mississauga
SKDS Research Incorporated, Newmarket
Gordon Sussman Clinical Research Incorporated, North York
JRB Research Incorporated, Ottawa
Fakultni nemocnice u sv Anny v Brne, Brno
Nemocnice Novy Jicin as, Nový Jičín
Fakultni nemocnice Ostrava, Ostrava-Poruba
Sanatorium profesora Arenbergera, Prague
Nemocnice Na Bulovce, Prague
Toho University Sakura Medical Center, Sakura-shi
Fukuoka University Hospital, Fukuoka
Takagi Dermatological Clinic, Obihiro-shi
Medical Corporation Kojinkai Sapporo Skin Clinic, Sapporo
Meiwa Hospital, Nishinomiya-shi
Nagasaki University Hospital, Nagasaki
Kume Clinic, Sakai-shi
Nippon Medical School Hospital, Bunkyo-ku
Japan Post Holdings Co Ltd Tokyo Teishin Hospital, Chiyoda-ku
NTT Medical Center Tokyo, Shinagawa-ku
Center Hospital of the National Center for Global Health and Medicine, Shinjuku-ku
Shirasaki Dermatology Clinic, Takaoka-shi
Uniwersyteckie Centrum Kliniczne, Gdansk
Centrum Terapii Wspolczesnej J M Jasnorzewska Spolka Komandytowo-Akcyjna, Lodz
Dermoklinika Centrum Medyczne Spolka cywilna M Kierstan J Narbutt A Lesiak, Lodz
Niepubliczny Zaklad Opieki Zdrowotnej Med Laser Borzecki Spolka Jawna, Lublin
Tomasz Blicharski Lubelskie Centrum Diagnostyczne, Świdnik
Centrum Medyczne Pratia Warszawa, Warsaw
Medicus Sp z o o, Wroclaw
DermMedica Spzoo, Wroclaw
Hallym University Kangnam Sacred Heart Hospital, Seoul
Hospital Universitari Germans Trias i Pujol, Badalona
Hospital del Mar, Barcelona
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital General Universitario de Alicante, Alicante
Medical clinic Blagomed, Kyiv
Ninewells Hospital, Dundee
Whipps Cross University Hospital, London
Southampton General Hospital, Southampton
Lead Sponsor
Collaborators (1)
AstraZeneca
INDUSTRY
Amgen
INDUSTRY